Gonzalo Barón Esquivias-rekin lankidetzan egindako argitalpenak (12)

2023

  1. Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment

    American Journal of Cardiology, Vol. 203, pp. 122-127

  2. Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban

    Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049

2022

  1. Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program

    Medicina Clinica, Vol. 159, Núm. 4, pp. 177-182

  2. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

    Cardiology Journal, Vol. 29, Núm. 6, pp. 936-947

  3. Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study

    Cardiology Journal, Vol. 29, Núm. 4, pp. 601-609

  4. Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries

    Journal of comparative effectiveness research, Vol. 11, Núm. 16, pp. 1173-1184

  5. Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

    European Journal of Clinical Investigation

2018

  1. Comments on the 2018 ESC Guidelines for the Diagnosis and Management of Syncope

    Revista Espanola de Cardiologia, Vol. 71, Núm. 10, pp. 787-793

2017

  1. Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice

    Expert Review of Cardiovascular Therapy, Vol. 15, Núm. 5, pp. 403-413

  2. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

    Journal of the American College of Cardiology, Vol. 69, Núm. 7, pp. 777-785

2012

  1. Comments on the ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation. A report of the task force of the clinical practice guidelines committee of the Spanish society of cardiology

    Revista Espanola de Cardiologia, Vol. 65, Núm. 2, pp. 125-130

  2. New evidence, new controversies: A critical review of the European society of cardiology 2010 clinical practice guidelines on atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 65, Núm. 1, pp. 7-13